Visible Abdominal Distension

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions
Irritable Bowel SyndromeDyspepsiaFunctional Bloating
Interventions
BEHAVIORAL

Biofeedback

Three sessions of biofeedback intervention will be performed during the first 3 weeks of the intervention period. Patients will be taught to control abdominal and thoracic muscular activity by providing instructions using an original video support. Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period

BEHAVIORAL

Placebo

Three sessions of placebo intervention will be performed during the first 3 weeks of the intervention period. Sham measurements of abdominal and thoracic motion will be performed, and a pill of placebo containing 0.21 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.

Trial Locations (7)

33000

Bordeaux University Hospital, Bordeaux

40138

Santa Orsola Hospital, Bologna

90095

G. Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles

ON L8S 4L8

McMaster University, Hamilton

08035

Hospital Universitari Vall d'Hebron, Barcelona

413 45

Sahlgrenska Hospital, Gothenburg, Gothenburg

M14 9PR

Manchester University, Manchester

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER